INTRODUCTION: The present study investigated the fitness and health effects of medium-term soccer training for untrained hypertensive middle-age men. METHODS:Thirty-three untrained males (31-54 yr) with mild-to-moderate hypertension were randomized 2:1 to a soccer training group (STG, two 1-h sessions per week, n = 22, 68% on medication) and a doctor advice group receiving traditional physician-guided recommendations on cardiovascular risk factor modification (DAG, n = 11, 73% on medication). Two-way repeated-measures ANOVA time-group statistics was applied. RESULTS: During soccer training, average HR was 155 ± 9 bpm or 85% ± 7% HRmax. In STG, systolic and diastolic blood pressures decreased (P < 0.01) over 6 months from 151 ± 10 to 139 ± 10 mm Hg and from 92 ± 7 to 84 ± 6 mm Hg, respectively, with smaller (P < 0.05) decreases in DAG (from 153 ± 8 to 145 ± 8 mm Hg and from 96 ± 6 to 93 ± 6 mm Hg, respectively). In STG, V˙O2max increased (P < 0.01) from 32.6 ± 4.9 to 35.4 ± 6.6 mL·min-1·kg-1 and relative V˙O2 during cycling at 100 W was lowered (P < 0.05) from 55% ± 7% to 50% ± 8% V˙O2max over 6 months, with no changes in DAG. In STG, resting HR was lowered by 8 ± 11 bpm (P < 0.05), and the augmentation index (a measure of arterial stiffness) was lowered (P < 0.05) by 7.3 ± 14.0 over 6 months, with no change in DAG. CONCLUSIONS: Six months of soccer training improved aerobic fitness, reduced blood pressure, and resulted in an array of other favorable effects on cardiovascular risk profile for untrained middle-age hypertensive men. Soccer training, therefore, may be a better nonpharmacological treatment for hypertensive men than traditional physician-guided advice.
RCT Entities:
INTRODUCTION: The present study investigated the fitness and health effects of medium-term soccer training for untrained hypertensive middle-age men. METHODS: Thirty-three untrained males (31-54 yr) with mild-to-moderate hypertension were randomized 2:1 to a soccer training group (STG, two 1-h sessions per week, n = 22, 68% on medication) and a doctor advice group receiving traditional physician-guided recommendations on cardiovascular risk factor modification (DAG, n = 11, 73% on medication). Two-way repeated-measures ANOVA time-group statistics was applied. RESULTS: During soccer training, average HR was 155 ± 9 bpm or 85% ± 7% HRmax. In STG, systolic and diastolic blood pressures decreased (P < 0.01) over 6 months from 151 ± 10 to 139 ± 10 mm Hg and from 92 ± 7 to 84 ± 6 mm Hg, respectively, with smaller (P < 0.05) decreases in DAG (from 153 ± 8 to 145 ± 8 mm Hg and from 96 ± 6 to 93 ± 6 mm Hg, respectively). In STG, V˙O2max increased (P < 0.01) from 32.6 ± 4.9 to 35.4 ± 6.6 mL·min-1·kg-1 and relative V˙O2 during cycling at 100 W was lowered (P < 0.05) from 55% ± 7% to 50% ± 8% V˙O2max over 6 months, with no changes in DAG. In STG, resting HR was lowered by 8 ± 11 bpm (P < 0.05), and the augmentation index (a measure of arterial stiffness) was lowered (P < 0.05) by 7.3 ± 14.0 over 6 months, with no change in DAG. CONCLUSIONS: Six months of soccer training improved aerobic fitness, reduced blood pressure, and resulted in an array of other favorable effects on cardiovascular risk profile for untrained middle-age hypertensivemen. Soccer training, therefore, may be a better nonpharmacological treatment for hypertensivemen than traditional physician-guided advice.
Authors: Jacob Uth; Therese Hornstrup; Jesper F Christensen; Karl B Christensen; Niklas R Jørgensen; Eva W Helge; Jakob F Schmidt; Klaus Brasso; Jørn W Helge; Markus D Jakobsen; Lars L Andersen; Mikael Rørth; Julie Midtgaard; Peter Krustrup Journal: Eur J Appl Physiol Date: 2015-11-30 Impact factor: 3.078
Authors: Therese Hornstrup; F T Løwenstein; M A Larsen; E W Helge; S Póvoas; J W Helge; J J Nielsen; B Fristrup; J L Andersen; L Gliemann; L Nybo; P Krustrup Journal: Eur J Appl Physiol Date: 2018-11-24 Impact factor: 3.078
Authors: Peter Krustrup; Eva Wulff Helge; Peter R Hansen; Per Aagaard; Marie Hagman; Morten B Randers; Maysa de Sousa; Magni Mohr Journal: Eur J Appl Physiol Date: 2017-11-21 Impact factor: 3.078
Authors: Amy E Mendham; Rob Duffield; Aaron J Coutts; Frank Marino; Andriy Boyko; David J Bishop Journal: PLoS One Date: 2015-06-01 Impact factor: 3.240
Authors: Jacob Uth; Jakob Friis Schmidt; Jesper Frank Christensen; Therese Hornstrup; Lars Juel Andersen; Peter Riis Hansen; Karl Bang Christensen; Lars Louis Andersen; Eva Wulff Helge; Klaus Brasso; Mikael Rørth; Peter Krustrup; Julie Midtgaard Journal: BMC Cancer Date: 2013-12-13 Impact factor: 4.430
Authors: Magni Mohr; Nikolai Baastrup Nordsborg; Annika Lindenskov; Hildigunn Steinholm; Hans Petur Nielsen; Jann Mortensen; Pal Weihe; Peter Krustrup Journal: Biomed Res Int Date: 2014-04-10 Impact factor: 3.411